References
- Perme MP, Estève J, Rachet B. Analysing population-based cancer survival – settling the controversies. BMC Cancer. 2016;16(1):933. doi:10.1186/s12885-016-2967-927912732
- Mariotto AB, Noone AM, Howlader N, et al. Cancer survival: an overview of measures, uses, and interpretation. J Natl Cancer Inst Monogr. 2014;2014(49):145–186. doi:10.1093/jncimonographs/lgu02425417231
- American Lung Association. Lung cancer fact sheet. Available from: http://www.lung.org/lung-health-and-diseases/lung-disease-lookup/lung-cancer/resource-library/lung-cancer-fact-sheet.html. Accessed 9 10, 2018.
- Munro AJ. Comparative cancer survival in European countries. Br Med Bull. 2014;110(1):5–22. doi:10.1093/bmb/ldu00924816203
- Cronin KA, Feuer EJ. Cumulative cause‐specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med. 2000;19(13):1729–1740.10861774
- Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol. 2010;39(2):598–610. doi:10.1093/ije/dyp39220142331
- Howlader N, Ries LA, Mariotto AB, et al. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010;102(20):1584–1598. doi:10.1093/jnci/djq36620937991
- Surveillance, Epidemiology, and End Results (SEER) Program Populations (1973–2014). Bethesda (MD): National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2017.
- Fritz A, Percy C, Jack A, et al. eds. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000 70–81.
- Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York (NY): Springer-Verlag; 2002.
- Ederer F, Heise H. The effect of eliminating deaths from cancer on general population survival rates. Meth Note No. 1959;11(23):169.
- Dickman P. Estimating and modelling relative survival using SAS. Available from: http://www.pauldickman.com/rsmodel/sas_colon/. Accessed 5 1, 2018.
- Cho H, Howlader N, Mariotto AB, et al. Estimating relative survival for cancer patients from the SEER program using expected rates based on Ederer I versus Ederer II method. Surveillance Research Program, NCI, Technical Report #2011-01. Available from: https://surveillance.cancer.gov/reports/tech2011.01.pdf. Published 2011 Accessed 52, 2018.
- Radivoyevitch T. SEERaBomb: SEER and atomic bomb survivor data analysis tools. R package version 2017.2. The Comprehensive R Archive Network; 2017 Available from: https://CRAN.R-project.org/package=SEERaBomb. Accessed 51, 2018.
- Hyndman RJ. Demography: forecasting mortality, fertility, migration and population data. R package version 1.18. The Comprehensive R Archive Network; 2014 Available from: https://CRAN.R-project.org/package=demography. Accessed 51, 2018
- National Center for Health Statistics (NCHS). United States life tables. Available from: https://www.cdc.gov/nchs/products/life_tables.htm. Accessed 51, 2018.
- Doria-Rose VP, Marcus PM. Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project. Lung Cancer. 2009;63(2):295–300. doi:10.1016/j.lungcan.2008.05.01918585822
- Frost JK, Ball WC, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis. 1984;130(4):549–554. doi:10.1164/arrd.1984.130.4.5496091505
- Tan KS. Misclassification of the actual causes of death and its impact on analysis: a case study in non-small cell lung cancer. Lung Cancer. 2019;134:16–24. doi:10.1016/j.lungcan.2019.05.01631319976
- Gamel JW, Vogel RL. Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients. Stat Methods Med Res. 2001;10(5):339–352. doi:10.1177/09622802010100050311697226
- Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5): Elsevier. doi:10.1016/S0025-6196(11)60735-0
- Willett WC, Green A, Stampfer MJ, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med. 1987;317(21):1303–1309. doi:10.1056/NEJM1987111931721023683458
- Moore C. Cigarette smoking and cancer of the mouth, pharynx, and larynx: a continuing study. Jama. 1971;218(4):553–558.5171003
- Fuchs CS, Colditz GA, Stampfer MJ, et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med. 1996;156(19):2255–2260.8885826
- Blakely T, Soeberg M, Carter K, et al. Bias in relative survival methods when using incorrect life‐tables: lung and bladder cancer by smoking status and ethnicity in New Zealand. Int J Cancer. 2012;131(6):E974–E982. doi:10.1002/ijc.2759222419246
- Hinchliffe SR, Rutherford MJ, Crowther MJ, et al. Should relative survival be used with lung cancer data? Br J Cancer. 2012;106(11):1854–1859. doi:10.1038/bjc.2012.18222555396
- Ellis L, Coleman MP, Rachet B. The impact of life tables adjusted for smoking on the socio-economic difference in net survival for laryngeal and lung cancer. Br J Cancer. 2014;111(1):195–202. doi:10.1038/bjc.2014.21724853177
- Rosenberg MA, Feuer EJ, Yu B, et al. Chapter 3: cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Anal. 2012;32(Suppl 1):S25–S38. doi:10.1111/j.1539-6924.2011.01662.x22882890
- Hinchliffe SR, Dickman PW, Lambert PC. Adjusting for the proportion of cancer deaths in the general population when using relative survival: a sensitivity analysis. Cancer Epidemiol. 2012;36(2):148–152. doi:10.1016/j.canep.2011.09.00722000329
- Ellison LF. Adjusting relative survival estimates for cancer mortality in the general population. Health Rep. 2014;25(11):3–9.
- Talbäck M, Dickman PW. Estimating expected survival probabilities for relative survival analysis—exploring the impact of including cancer patient mortality in the calculations. Eur J Cancer. 2011;47(17):2626–2632. doi:10.1016/j.ejca.2011.08.01021924892
- Hakulinen T, Seppä K, Lambert PC. Choosing the relative survival method for cancer survival estimation. Eur J Cancer. 2011;47(14):2202–2210. doi:10.1016/j.ejca.2011.03.01121549589
- Seppä K, Hakulinen T, Läärä E, et al. Comparing net survival estimators of cancer patients. Stat Med. 2016;35(11):1866–1879. doi:10.1002/sim.683326707551
- Roche L, Danieli C, Belot A, et al. Cancer net survival on registry data: use of the new unbiased Pohar‐Perme estimator and magnitude of the bias with the classical methods. Int J Cancer. 2013;132(10):2359–2369. doi:10.1002/ijc.2783022961565
- Perme MP, Stare J, Esteve J. On estimation in relative survival. Biometrics. 2012;68:113–120. doi:10.1111/j.1541-0420.2011.01640.x21689081
- Lambert PC, Dickman PW, Rutherford MJ. Comparison of different approaches to estimating age standardized net survival. BMC Med Res Methodol. 2015;15(1):64. doi:10.1186/s12874-015-0092-026275405